Tenofovir Alafenamide Fumarate Tablets 25?mg (Zhongyan) – Low price wholesale

Tenofovir Alafenamide Fumarate Tablets 25?mg (Zhongyan) – Low price wholesale

(1 customer review)

$2.00

Zhongyan Tenofovir Alafenamide Fumarate Tablets contain 25?mg of active drug per tablet in a bottle of 30 tablets. Manufactured by Tianjin Institute of Pharmaceutical Research and approved under NMPA H20233581. Ideal for use in hepatitis B research, viral suppression studies, and pharmacokinetic analysis.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Tenofovir alafenamide (TAF) is a potent nucleotide reverse transcriptase inhibitor (NRTI) and prodrug of tenofovir. It is used in research models of chronic hepatitis B and HIV due to its ability to inhibit viral polymerase while offering improved renal and bone safety profiles relative to older formulations. This compact tablet form supports accurate dosing, compliance in animal models, and studies of antiviral efficacy and pharmacodynamics.


Tenofovir Alafenamide Fumarate Product Specifications

ParameterDetails
Product NameTenofovir Alafenamide Fumarate Tablets (Zhongyan)
Generic NameTenofovir Alafenamide Fumarate
CAS Number379270?37?8
Molecular FormulaC??H??N?O?P
Molecular Weight~476.47?Da
FormulationFilm-coated oral tablet
Strength25?mg per tablet
Pack Size30 tablets per bottle
Dosage FormTablet
Approval NumberH20233581
Drug Standard Code86900951000657
ManufacturerTianjin Institute of Pharmaceutical Research Co., Ltd.
Barcode6927355700918
Storage ConditionsStore below 25?°C, sealed in original container, protect from moisture/light
Intended UseLaboratory and preclinical research use

Tenofovir Alafenamide Fumarate Mechanism of Action

TAF acts as an NRTI by delivering tenofovir directly into infected cells, inhibiting HBV and HIV reverse transcriptase enzymes. It achieves high intracellular drug levels while maintaining lower systemic exposure and improved safety.


Tenofovir Alafenamide Fumarate Research Application Areas

  • Chronic hepatitis B virus suppression

  • HIV/HBV coinfection studies

  • Pharmacokinetic and pharmacodynamic evaluations

  • Resistance mutation and antiviral efficacy screening

  • Comparative toxicity and safety profiling


Safety & Handling

  • Handling: Laboratory PPE (gloves, coat, goggles) required.

  • Storage: Below 25?°C, dry, and shielded from light.

  • Precautions: Not for human or veterinary use; follow institutional biosafety guidelines.


Core Keywords

Tenofovir Alafenamide tablets, TAF 25mg Zhongyan, CAS 379270?37?8, HBV antiviral research, NRTI lab tablets, H20233581 tenofovir alafenamide, wholesale antiviral tablets, research-grade TAF tablets


Research Use Disclaimer

For preclinical and scientific research use only. Not for medical, clinical, diagnostic, or veterinary purposes. Misuse may carry regulatory, legal, or health risks. Use under approved institutional protocols only.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

1 review for Tenofovir Alafenamide Fumarate Tablets 25?mg (Zhongyan) – Low price wholesale

  1. bravoe

    ??? ?? ???? ???

Add a review

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare